Merck President of Global Human Health to Step Down
December 10 2018 - 5:25PM
Dow Jones News
Merck & Co. Inc. (MRK) on Monday said Adam H. Schechter,
president of Global Human Health, is stepping down from his current
position as of Dec. 31, and will be shifting to an advisory
capacity to the chief executive.
In addition, Merck said it "is taking the opportunity to reshape
its commercial organization and is creating two new Executive
Committee roles," promoting Frank Clyburn to chief commercial
officer and Michael Nally to chief marketing officer.
Mr. Schechter, who joined the company in 1988, has been the
president of Merck's human health business since 2010.
"Adam's leadership and unwavering dedication to finding new ways
to bring Merck's medicines and vaccines to more patients around the
world have been hallmarks of his time at Merck," Merck Chairman and
Chief Executive Officer Kenneth C. Frazier said in a statement. "I
have relied on his experience and expertise as we evolved a
world-class commercial organization, spanning primary care,
hospital and specialty, vaccines and oncology. Because of him we
are better positioned to address future opportunities and
challenges as a global biopharmaceutical company, and Frank and
Mike have a great foundation upon which to build future
success."
Mr. Clyburn and Mr. Nally will start their new roles on Jan. 1,
2019. Mr. Clyburn most recently has served as president of the
Global Oncology business. Mr. Nally most recently led the company's
Vaccines business.
Write to copydesk@dowjones.com
(END) Dow Jones Newswires
December 10, 2018 17:10 ET (22:10 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024